Cargando…
Cutting Edge Molecular Therapy for Acute Myeloid Leukemia
Recently, whole exome sequencing for acute myeloid leukemia (AML) has been performed by a next-generation sequencer in several studies. It has been revealed that a few gene mutations are identified per AML patient. Some of these mutations are actionable mutations that affect the response to an appro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404220/ https://www.ncbi.nlm.nih.gov/pubmed/32698349 http://dx.doi.org/10.3390/ijms21145114 |